CompaniesByCap
RNAC
Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare

Cartesian Therapeutics Inc. Cash Flow 2014–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-73.9M-23.7M-51.2M-31.6M-60.4M34.9M-51.4M-59.2M-52.0M-19.8M-22.5M
Depreciation & Amort.
Investing Activities
Capital Expenditure5.5M9.1M206,0001.2M1.1M815,00047,000884,000733,000586,0001.2M
Free Cash Flow-79.4M-32.8M-51.4M-32.8M-61.5M34.1M-51.5M-60.0M-52.8M-20.3M-23.6M
Financing Activities
Dividends Paid
Stock Buybacks

Cartesian Therapeutics Inc. Cash Flow — FAQ

Cartesian Therapeutics Inc. (RNAC) cash flow over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNAC's cash flow history?

The chart and table above show Cartesian Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.